Neutral editorial coverage examining institutional commentary, healthcare sector context, and index association surrounding a respiratory medical technology provider within established United States ...

Revenue increased by 11% to $1.4 billion; up 9% on a constant currency basis Gross margin up 320 bps to 61.8%; non-GAAP gross margin up 310 bps to 62.3%Income from operations increased 18%; non-GAAP ...

Shares in ResMed Inc. experienced a significant surge, rising 5.2 per cent in morning trade following the release of its ...

Thank you, Sally, and good morning, good afternoon, good evening to all of our shareholders, and welcome to all to ResMed's second quarter fiscal year 2026 earnings call. For this March and the June ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal second-quarter net income of $392.6 million.

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what you need to know.

Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including ...

ResMed (NYSE:RMD) supports global respiratory care as s&p 500 chart discussions frame large healthcare organizations.

If you are wondering whether ResMed's current share price still offers value, this article walks through what the numbers are ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the ...

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...

Sleep apnea device maker ResMed will expand its American manufacturing operations and open a new facility in Indianapolis in 2027 but says it is not due to pressure from President Donald Trump for ...